Insights & Resources

The DOJ’s updated compliance guidelines require proactive AI risk management. Take steps to ensure your company meets the standards.

J.P. Morgan's Q1 2025 biopharma and medtech reports reveal larger deals, global growth and financial strategies shaping the life sciences industry.

Within the changing landscape of educational technology, schools face new risk factors that affect students, faculty and administrators.

Learn how financial institutions can manage third-party risks, protect customer trust and minimize disruptions from critical service outages.

J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.

The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.

The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.

PCI DSS sets the standard for payment card security in higher education detailing compliance levels, reporting requirements and strategies to protect data.

AI is revolutionizing industries, but misleading claims are rampant. Learn how the SEC combats AI washing and the importance of transparency for investment advisers.

Change Healthcare was impacted by a cybersecurity incident that breached its information technology network.

In a business sale, due diligence is critical to mitigate the risk of unexpected tax issues for buyers and sellers. Find out key components of tax due diligence.

Administrative, physical, and technical safeguards are an essential element of HIPAA security and essential for protecting PHI and ePHI.